XML 81 R62.htm IDEA: XBRL DOCUMENT
v3.24.1.u1

Legal Proceedings (Details) $ in Millions |  | 1 Months Ended | 3 Months Ended |  |  |  |
--- | --- | --- | --- | --- | --- | --- | ---
May 01, 2024 USD ($) | Oct. 31, 2021 entity | Jun. 30, 2021 USD ($) | Jun. 30, 2020 USD ($) | Jan. 31, 2020 USD ($) | Oct. 31, 2019 USD ($) | Jul. 31, 2018 USD ($) | Mar. 31, 2024 USD ($) claim claimant | Dec. 29, 2024 | Jan. 02, 2022 USD ($) | Sep. 30, 2021 cases | May 31, 2021 cases claimant
Legal Proceeding (Textuals) |  |  |  |  |  |  |  |  |  |  |  |
Number of new entities created | entity |  | 3 |  |  |  |  |  |  |  |  |  |
Judicial Ruling |  |  |  |  |  |  |  |  |  |  |  |
Legal Proceeding (Textuals) |  |  |  |  |  |  |  |  |  |  |  |
Damages awarded |  |  |  |  | $ 6.8 | $ 8,000.0 |  |  |  |  |  |
Opioid |  |  |  |  |  |  |  |  |  |  |  |
Legal Proceeding (Textuals) |  |  |  |  |  |  |  |  |  |  |  |
Loss contingency accrual |  |  |  |  |  |  |  |  |  | $ 5,000.0 |  |
Number of pending claims | claim |  |  |  |  |  |  |  | 35 |  |  |  |
Product liability contingency, number of claimants | claimant |  |  |  |  |  |  |  | 3,500 |  |  |  |
Loss contingency accrual, payment percentage |  |  |  |  |  |  |  | 60.00% |  |  |  |
Pending claims, number, remaining | claim |  |  |  |  |  |  |  | 435 |  |  |  |
Loss contingency pending claims, number, additional | claim |  |  |  |  |  |  |  | 4 |  |  |  |
Opioid | Scenario, Forecast |  |  |  |  |  |  |  |  |  |  |  |
Legal Proceeding (Textuals) |  |  |  |  |  |  |  |  |  |  |  |
Loss contingency accrual, payment percentage |  |  |  |  |  |  |  |  | 75.00% |  |  |
Physiomesh |  |  |  |  |  |  |  |  |  |  |  |
Legal Proceeding (Textuals) |  |  |  |  |  |  |  |  |  |  |  |
Product liability contingency, number of claimants | claimant |  |  |  |  |  |  |  | 230 |  |  |  |
Physiomesh | Pending Litigation |  |  |  |  |  |  |  |  |  |  |  |
Legal Proceeding (Textuals) |  |  |  |  |  |  |  |  |  |  |  |
Number of pending claims | cases |  |  |  |  |  |  |  |  |  |  |  | 3,600
Product liability contingency, number of claimants | claimant |  |  |  |  |  |  |  |  |  |  |  | 4,300
Number of claims within settlement agreement | cases |  |  |  |  |  |  |  |  |  |  | 3,729 |
Ingham v. Johnson & Johnson |  |  |  |  |  |  |  |  |  |  |  |
Legal Proceeding (Textuals) |  |  |  |  |  |  |  |  |  |  |  |
Damages awarded |  |  |  | $ 2,100.0 |  |  | $ 4,700.0 |  |  |  |  |
Damages paid |  |  | $ 2,500.0 |  |  |  |  |  |  |  |  |
DePuy ASR U.S. | Settled Litigation |  |  |  |  |  |  |  |  |  |  |  |
Legal Proceeding (Textuals) |  |  |  |  |  |  |  |  |  |  |  |
Number of patients in settlement | claimant |  |  |  |  |  |  |  | 10,000 |  |  |  |
Talc |  |  |  |  |  |  |  |  |  |  |  |
Legal Proceeding (Textuals) |  |  |  |  |  |  |  |  |  |  |  |
Incremental charges |  |  |  |  |  |  |  | $ 2,700.0 |  |  |  |
Loss contingency accrual |  |  |  |  |  |  |  | 11,000.0 |  |  |  |
Loss contingency accrual, nominal value |  |  |  |  |  |  |  | $ 13,700.0 |  |  |  |
Talc | Subsequent Event |  |  |  |  |  |  |  |  |  |  |  |
Legal Proceeding (Textuals) |  |  |  |  |  |  |  |  |  |  |  |
Litigation contingency | $ 6,475.0 |  |  |  |  |  |  |  |  |  |  |
Payment period | 25 years |  |  |  |  |  |  |  |  |  |  |
Damages sought, nominal value | $ 8,400.0 |  |  |  |  |  |  |  |  |  |  |
Bankruptcy loss contingency, discount rate | 4.40% |  |  |  |  |  |  |  |  |  |  |
Total claims against company, percent | 99.75% |  |  |  |  |  |  |  |  |  |  |
Mesothelioma and State Claims | Subsequent Event |  |  |  |  |  |  |  |  |  |  |  |
Legal Proceeding (Textuals) |  |  |  |  |  |  |  |  |  |  |  |
Claims settled, percent | 95.00% |  |  |  |  |  |  |  |  |  |  |

X
- Definition Legal Proceeding Textuals Abstract. + References No definition available. + Details
Name: | jnj_LegalProceedingTextualsAbstract
Namespace Prefix: | jnj_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Loss Contingency Accrual, Nominal Value + References No definition available. + Details
Name: | jnj_LossContingencyAccrualNominalValue
Namespace Prefix: | jnj_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Loss contingency accrual, payment percentage + References No definition available. + Details
Name: | jnj_LossContingencyAccrualPaymentPercentage
Namespace Prefix: | jnj_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | instant

X
- Definition Loss Contingency, Claims Settled, Percent + References No definition available. + Details
Name: | jnj_LossContingencyClaimsSettledPercent
Namespace Prefix: | jnj_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Loss Contingency, Damages Sought, Nominal Value + References No definition available. + Details
Name: | jnj_LossContingencyDamagesSoughtNominalValue
Namespace Prefix: | jnj_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Loss Contingency, Discount Rate + References No definition available. + Details
Name: | jnj_LossContingencyDiscountRate
Namespace Prefix: | jnj_
Data Type: | dtr-types1:percentItemType
Balance Type: | na
Period Type: | instant

X
- Definition Loss Contingency, Number of Claims within Settlement Agreement + References No definition available. + Details
Name: | jnj_LossContingencyNumberOfClaimsWithinSettlementAgreement
Namespace Prefix: | jnj_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | instant

X
- Definition Loss Contingency, Payment Period + References No definition available. + Details
Name: | jnj_LossContingencyPaymentPeriod
Namespace Prefix: | jnj_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Loss Contingency Pending Claims, Number, Additional + References No definition available. + Details
Name: | jnj_LossContingencyPendingClaimsNumberAdditional
Namespace Prefix: | jnj_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | instant

X
- Definition Loss Contingency, Pending Claims, Number, Remaining + References No definition available. + Details
Name: | jnj_LossContingencyPendingClaimsNumberRemaining
Namespace Prefix: | jnj_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | instant

X
- Definition Number Of New Entities Created + References No definition available. + Details
Name: | jnj_NumberOfNewEntitiesCreated
Namespace Prefix: | jnj_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | duration

X
- Definition Number of patients in settlement + References No definition available. + Details
Name: | jnj_Numberofpatientsinsettlement
Namespace Prefix: | jnj_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | instant

X
- Definition Product liability contingency number of claimant. + References No definition available. + Details
Name: | jnj_ProductLiabilityContingencyNumberOfClaimant
Namespace Prefix: | jnj_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | instant

X
- Definition Total Claims Against Company, Percent + References No definition available. + Details
Name: | jnj_TotalClaimsAgainstCompanyPercent
Namespace Prefix: | jnj_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Amount of loss contingency liability. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 450 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org//1943274/2147483076/450-20-50-1 Reference 2: http://www.xbrl.org/2003/role/recommendedDisclosureRef -Topic 450 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 10 -Publisher FASB -URI https://asc.fasb.org//1943274/2147483076/450-20-50-10 + Details
Name: | us-gaap_LossContingencyAccrualAtCarryingValue
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Amount charged against operating income increasing loss contingency liability, after adjustments to reduce previously estimated charges. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 450 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org//1943274/2147483076/450-20-50-1 + Details
Name: | us-gaap_LossContingencyAccrualProvision
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Amount of damages awarded to the plaintiff in the legal matter. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 450 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org//1943274/2147483076/450-20-50-1 Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 450 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 4 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147483076/450-20-50-4 Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 450 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 9 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147483076/450-20-50-9 + Details
Name: | us-gaap_LossContingencyDamagesAwardedValue
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Amount of damages paid to the plaintiff in the legal matter. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 450 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org//1943274/2147483076/450-20-50-1 Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 450 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 4 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147483076/450-20-50-4 Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 450 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 9 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147483076/450-20-50-9 + Details
Name: | us-gaap_LossContingencyDamagesPaidValue
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition The value (monetary amount) of the award the plaintiff seeks in the legal matter. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 450 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org//1943274/2147483076/450-20-50-1 Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 450 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 4 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147483076/450-20-50-4 Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 450 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 9 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147483076/450-20-50-9 + Details
Name: | us-gaap_LossContingencyDamagesSoughtValue
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Number of pending claims pertaining to a loss contingency. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 450 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 4 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147483076/450-20-50-4 Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 450 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 9 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147483076/450-20-50-9 + Details
Name: | us-gaap_LossContingencyPendingClaimsNumber
Namespace Prefix: | us-gaap_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | instant

X
- Details
Name: | us-gaap_LitigationStatusAxis=us-gaap_JudicialRulingMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=jnj_OpioidMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_StatementScenarioAxis=srt_ScenarioForecastMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=jnj_PhysiomeshMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_LitigationStatusAxis=us-gaap_PendingLitigationMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_LitigationCaseAxis=jnj_InghamVsJohnsonJohnsonMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_LitigationCaseAxis=jnj_DePuyASRU.S.Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_LitigationStatusAxis=us-gaap_SettledLitigationMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_LitigationCaseAxis=jnj_TalcMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_LitigationCaseAxis=jnj_MesotheliomaAndStateClaimsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |